ARS Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 10.86 M | $114.58 M | 0.00% | 11.19% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 10.51 M | $110.93 M | -5.08% | 10.84% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 8.29 M | $87.44 M | 0.00% | 8.54% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 4.57 M | $48.26 M | 7.74% | 4.71% |
| SR ONE CAPITAL MANAGEMENT, LP | 02/13/2025 | 4.01 M | $42.34 M | 0.00% | 4.14% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 3.88 M | $40.94 M | 5,168.44% | 4.00% |
| VANGUARD GROUP INC | 02/11/2025 | 3.46 M | $36.56 M | 3.45% | 3.57% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 1.98 M | $20.85 M | -30.34% | 2.04% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 1.25 M | $13.23 M | 902.98% | 1.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.24 M | $13.07 M | 0.27% | 1.28% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.12 M | $11.81 M | 13.52% | 1.15% |
| FMR LLC | 02/13/2025 | 1.10 M | $11.63 M | 1.46% | 1.14% |
| UBS GROUP AG | 02/14/2025 | 1.01 M | $10.68 M | 821.63% | 1.04% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 939,278 | $9.91 M | 92.97% | 0.97% |
| NEXTECH INVEST LTD. | 02/14/2025 | 936,729 | $9.88 M | -15.84% | 0.97% |
| ROYCE & ASSOCIATES LP | 02/10/2025 | 929,613 | $9.81 M | 34.44% | 0.96% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 886,117 | $9.35 M | 221.23% | 0.91% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 623,281 | $6.58 M | 100.00% | 0.64% |
| FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 593,291 | $6.26 M | 0.00% | 0.61% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 500,000 | $5.28 M | 100.00% | 0.52% |
| LEVIN CAPITAL STRATEGIES, L.P. | 02/05/2025 | 467,627 | $4.93 M | 73.56% | 0.48% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 427,477 | $4.51 M | 0.83% | 0.44% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 01/31/2025 | 423,561 | $4.47 M | 100.00% | 0.44% |
| WEXFORD CAPITAL LP | 02/14/2025 | 369,497 | $3.90 M | 48.78% | 0.38% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 344,941 | $3.64 M | 1,431.85% | 0.36% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/29/2025 | 344,171 | $3.63 M | 93.11% | 0.35% |
| BANK OF MONTREAL /CAN/ | 02/13/2025 | 340,591 | $3.59 M | 100.00% | 0.35% |
| NEUBERGER BERMAN GROUP LLC | 02/13/2025 | 286,846 | $3.03 M | 16.63% | 0.30% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 247,314 | $2.61 M | 5.45% | 0.25% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 196,458 | $2.07 M | 2.08% | 0.20% |
| NICHOLAS INVESTMENT PARTNERS, LP | 02/14/2025 | 172,018 | $1.81 M | -14.75% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 171,385 | $1.81 M | 16.36% | 0.18% |
| MIURA GLOBAL MANAGEMENT, LLC | 02/14/2025 | 170,000 | $1.79 M | -37.04% | 0.18% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 163,252 | $1.72 M | 0.56% | 0.17% |
| BARCLAYS PLC | 02/13/2025 | 158,180 | $1.67 M | 41.65% | 0.16% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 157,951 | $1.67 M | 0.00% | 0.16% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 140,372 | $1.48 M | 72.71% | 0.14% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 130,289 | $1.37 M | 228.22% | 0.13% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 130,238 | $1.37 M | -1.04% | 0.13% |
| SEI INVESTMENTS CO | 02/11/2025 | 108,273 | $1.14 M | 100.00% | 0.11% |
| SECTORAL ASSET MANAGEMENT INC | 02/14/2025 | 106,007 | $1.12 M | 7.47% | 0.11% |
| STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 100,873 | $1.06 M | 274.85% | 0.10% |
| CITIGROUP INC | 02/12/2025 | 100,683 | $1.06 M | 170.49% | 0.10% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 98,078 | $1.03 M | -54.18% | 0.10% |
| FAS WEALTH PARTNERS, INC. | 02/14/2025 | 94,705 | $999,138 | 11.61% | 0.10% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 93,037 | $981,541 | -5.50% | 0.10% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 88,790 | $936,735 | -40.13% | 0.09% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 87,158 | $920,000 | 0.00% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 85,300 | $899,915 | -65.56% | 0.09% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 02/12/2025 | 83,225 | $878,024 | 0.00% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ARS Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 172 institutional investors and hedge funds held shares of ARS Pharmaceuticals, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.86 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 10.51 M
ORBIMED ADVISORS LLC: 8.29 M
BlackRock Funding, Inc. /DE: 4.57 M
SR ONE CAPITAL MANAGEMENT, LP: 4.01 M
ALLIANCEBERNSTEIN L.P.: 3.88 M
73.45% of ARS Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 73.15 M shares in the last 24 months. This purchase volume represents approximately $810.47 M in transactions.